Safety Study of ChimeriVax™-JE Vaccine to Prevent Japanese Encephalitis.
Public ClinicalTrials.gov record NCT00314132. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Randomised, Double Blind, Multicentre, Placebo Controlled Phase III Study of the Safety and Tolerability Following Administration of Live Attenuated JE Vaccine (ChimeriVax™-JE)
Study identification
- NCT ID
- NCT00314132
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Sanofi
- Industry
- Enrollment
- 2,004 participants
Conditions and interventions
Conditions
Interventions
- ChimeriVax-JE, Japanese Encephalitis vaccine Biological
- 0.9% Saline Biological
Biological
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 30, 2005
- Primary completion
- Oct 31, 2006
- Completion
- Oct 31, 2006
- Last update posted
- Dec 5, 2012
2005 – 2006
United States locations
- U.S. sites
- 16
- U.S. states
- 10
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Burbank | California | 92505 | — |
| Not listed | Costa Mesa | California | 92708 | — |
| Not listed | Davis | California | 95616 | — |
| Not listed | San Francisco | California | 94102 | — |
| Not listed | Vallejo | California | 94589 | — |
| Not listed | Miami | Florida | 33173 | — |
| Not listed | Orlando | Florida | 32809 | — |
| Not listed | Pembroke Pines | Florida | 33024 | — |
| Not listed | Iowa City | Iowa | 52242 | — |
| Not listed | Overland Park | Kansas | 66212 | — |
| Not listed | Bardstown | Kentucky | 40004 | — |
| Not listed | Livonia | Michigan | 48152 | — |
| Not listed | Sprnigfield | Missouri | 65802 | — |
| Not listed | Omaha | Nebraska | 68134 | — |
| Not listed | Winston-Salem | North Carolina | 27109 | — |
| Not listed | Fort Worth | Texas | 76135 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 6 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00314132, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 5, 2012 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00314132 live on ClinicalTrials.gov.